Skip to main content
logo
Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
106.41
+0.93 (0.88%)
At close: Aug 6, 2026, 4:00 PM EDT
108.53
+2.12 (1.99%)
After-hours: Aug 6, 2026, 7:54 PM EDT

Kymera Therapeutics Revenue

Kymera Therapeutics had revenue of $65.00M in the quarter ending June 30, 2026, with 466.40% growth. This brings the company's revenue in the last twelve months to $105.00M, up 134.84% year-over-year. In the year 2025, Kymera Therapeutics had annual revenue of $39.21M, down -16.70%.

Revenue (ttm)
$105.00M
Revenue Growth
+134.84%
P/S Ratio
84.27
Revenue / Employee
$415,020
Employees
253
Market Cap
8.85B

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202539.21M-7.86M-16.70%
Dec 31, 202447.07M-31.52M-40.11%
Dec 31, 202378.59M31.77M67.84%
Dec 31, 202246.83M-26.01M-35.71%
Dec 31, 202172.83M38.80M114.00%
Dec 31, 202034.03M31.10M1,059.99%
Dec 31, 20192.93M--
Dec 31, 20182.93M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Halozyme Therapeutics1.51B
Ionis Pharmaceuticals874.09M
Krystal Biotech440.48M
Protagonist Therapeutics281.99M
Rhythm Pharmaceuticals239.92M
ImmunityBio165.79M
Crinetics Pharmaceuticals42.16M
Revenue Rankings

KYMR News

More News